Vascular endothelial growth factor causes pulmonary vasodilation through activation of the phosphatidylinositol-3-kinase-nitric oxide pathway in the late-gestation ovine fetus

Pediatric Research

Volumn 52, Issue 6, 2002, Pages 907-912

  Grover, Theresa R ^a,b   Zenge, Jeanne P ^a   Parker, Thomas A ^a   Abman, Steven H ^a  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; VASCULOTROPIN; 2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; ENDOTHELIAL CELL GROWTH FACTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; LYMPHOKINE; MORPHOLINE DERIVATIVE; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN; RECOMBINANT PROTEIN; SIGNAL PEPTIDE; VASCULOTROPIN A;

AORTA; ARTICLE; ENZYME ACTIVATION; FETUS; GESTATIONAL AGE; HEART LEFT ATRIUM PRESSURE; HEMODYNAMICS; LUNG ARTERY; LUNG ARTERY PRESSURE; LUNG CIRCULATION; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; VASODILATATION; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; METABOLISM; PREGNANCY; SHEEP;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CHROMONES; ENDOTHELIAL GROWTH FACTORS; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; FETUS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MORPHOLINES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; NITROARGININE; PREGNANCY; PULMONARY CIRCULATION; RECOMBINANT PROTEINS; SHEEP; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VASODILATION;

EID: 85047682608     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200212000-00016     Document Type: Article

References (39)

1. Ferrara N, Henzel WJ 1989 Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858
2. Leung DW, Cacianes G, Kuang WJ, Goedel DV, Ferrara N 1989 Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309
3. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF 1983 Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985
4. Carmeliet P, Ferrara V, Breier G, Pollefeyt S, Kieckens, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A 1996 Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439
5. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea SK, Powell-Braxton L, Hillan KJ, Moore MW 1996 Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442
6. Lui W, Ahmad SA, Reinmuth N, Shaheen RM, Sung YD, Fan F, Ellis LM 2000 Endothelial cell survival and apoptosis in the tumor vasculature. Apoptosis 5:323-328
7. Gupta K, Kshirsagar S, Li W, Gui L, Ramakrishnan S, Gupta P, Law PY, Gebbel RP 1999 VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. Exp Cell Res 247:495-504
8. Kroll J, Waltenberger J 1998 VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 252:743-746
9. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM 1995 Recovery of disturbed endothelium-dependent flow in the collateralperfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation 91:2802-2809
10. Ku DD, Zaleski JK, Liu S, Brock TA 1993 Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol 265:H585-H592
11. Yang R, Thomas GR, Bunting S, Ko A, Ferrara N, Keyt B, Ross J, Jun H 1996 Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J Cardiovasc Pharmacol 27:838-844
12. Lopez JJ, Laham RJ, Carrozza JP, Tofukuji M, Sellke FW, Bunting S, Simons M 1997 Hemodynamic effects of intracoronary VEGF delivery: Evidence of tachyphylaxis and NO dependence of response. Am J Physiol 273:H1317-H1323
13. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM 1995 Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vase Surg 21:314-325
14. Takeshita S, Zheng LP, Brogi E, Keamey M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM 1994 Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93:662-670
15. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, Epstein SE, Unger EF 1994 Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89:2183-2189
16. Losordo DW, Vale PR, Isner JM 1999 Reperfusion therapy: Gene therapy for myocardial angiogenesis. Am Heart J 138:S132-S141
17. Hood JD, Meininger CJ, Ziche M, Granger HJ 1998 VEGF upregulates ecNOS message, protein and NO production in human endothelial cells. Am J Physiol 274:H1054-H1058
18. Horowitz JR, Rivard A, Van der Zee R, Hariawala M, Sheriff DD, Esakof DD, Chaudhry GM, Symes JF, Isner JM 1997 Vascular endothelial growth factor/vascular permeability factor produces nitric-oxide dependent hypotension. Arterioscler Thromb Vase Biol 17:2793-2800
19. Fulton D, Gratton JP, McCabe FJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC 1999 Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601
20. Kitayama J, Kitazono T, Ibayashi S, Wakisaka M, Watanabe Y, Kamouchi M, Nagao T, Fujishima M 2000 Role of phosphatidyl 3-kinase in acetylcholine-induced dilation of rat basilar artery. Stroke 31:2487-2493
21. Vlahos CJ, Matter WF, Hui KY, Brown RF 1994 A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269:5241-5248
22. Qi JH, Claesson-Welsh L 2001 VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase. Exp Cell Res 263:173-182
23. Lewis AB, Heymann MA, Rudolph AM 1976 Gestational changes in pulmonary vascular responses in fetal lambs in utero. Circ Res 39:536-541
24. Cornfield DF, Chatfied BA, McQueston JA, McMurtry IF, Abman SH 1992 Effects of birth-related stimuli on L-arginine-dependent pulmonary vasodilation in ovine fetus. Am J Physiol 262:H1474-H1481
25. Hu L, Zaloudek C, Mills GB, Gray J, Jaffe RB 2000 In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol-3-kinase inhibitor (LY294002). Clin Cancer Res 6:880-886
26. Acarregui MJ, Penisten ST, Goss KL, Ramirez K, Snyder JM 1999 Vascular endothelial growth factor gene expression in human fetal lung in vitro. Am J Respir Cell Mol Biol 20:14-23
27. Bhatt AJ, Amin SB, Chess PR, Watkins RH, Maniscalco WM 2000 Expression of vascular endothelial growth factor and Flk-1 in developing and glucocorticoid treated mouse lung, Pediatr Res 47:606-613
28. Yang R, Bunting S, Ko A, Keyt BA, Modi NB, Zioncheck TF, Ferrara N, Jun H 1998 Substantially attenuated hemodynamic responses to Escherichia coli-derived vascular endothelial growth factor given by intravenous infusion compared with bolus injection. J Pharmacol Exp Ther 284:103-110
29. Hariawala MD, Horowitz JF, Esakof D, Sheriff DD, Walter DH, Dety B, Isner JM, Symes JF 1996 VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J Surg Res 63:77-82
30. Harada K, Friedman M, Lopez JJ, Wang Sy, Li J, Prasad PV, Pearlman JD, Edelman ER, Sellke FW, Simons M 1996 Vascular endothelial growth factor in chronic myocardial ischemia. Am J Physiol 270:H1791-H1802
31. Partovian C, Adnot S, Eddahibi S, Teiger E. Levame M, Dreyfus P, Raffenstin B, Frelin C 1998 Heart and lung VEGF mRNA expression in rats with monocrotalineor hypoxia-induced pulmonary hypertension. Am J Physiol 275:H1948-H1956
32. Christou H, Yoshida A, Arthur V, Morita T, Kourembanas S 1998 Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol 18:768-776
33. Parker TA, Le Cras TD, Kinsella JP, Abman SH 2000 Developmental changes in endothelial nitric oxide synthase expression and activity in ovine fetal lung. Am J Physiol 278:L202-L208
34. Accurso FJ, Wilkening RB 1988 Temporal response of the fetal pulmonary circulation to pharmacologic vasodilators. Proc Soc Exp Biol Med 187:89-98
35. Accurso FJ, Albert B, Wilkening RB, Petersen RG, Meschia G 1986 Time-dependent response of fetal pulmonary blood flow to an increase in fetal oxygen tension. Respir Physiol 63:43-52
36. Abman SH, Wilkening RB, Ward RM, Accurso FJ 1986 Adaptation of fetal pulmonary blood flow to local infusion of tolazoline. Pediatr Res 20:1131-1135
37. Tucker A, Brown DT, Greenlees KJ 1982 Pulmonary and systemic vascular actions of tolazoline in anesthetized dogs. Pediatr Pharmacol 2:231-243
38. Nakanishi S, Yano H, Matsuda Y 1995 Novel functions of phosphatidylinositol 3-kinase in terminally differentiated cells. Cell Signal 7:545-557
39. Irani C, Goncharova EA, Hunter DS, Walker CL, Panettieri RA, Drymdkaya VP 2002 Phosphatidylinositol-3-kinase but not tuberin is required for PDGF-induced cell migration. Am J Physiol 282:L854-L862